Home Blog Page 100

Blog

Pharma Marketing Blog

Most popular

What’s in the Future for Generics?

Pharma Guy - April 24, 2007

Vagelos Speaks, Will Pharma Listen?

Pharma Guy - September 15, 2005

“Selling That New-Man Feeling” – NYT Quotes Pharmaguy on Low-T Marketing

Pharma Guy - November 24, 2013

Pharma eMarketing at Tipping Point?

Pharma Guy - June 30, 2005

What’s the Cause of the Drug Industry’s Bad Reputation?

Pharma Guy - March 16, 2009

Let Us Fear the Price of “Cutting-Edge” Drugs!

Pharma Guy - May 7, 2013

Drug Prices/Declining Profits Top Issues for 2005

Pharma Guy - January 18, 2005

FDA’s Ten Commandments

Pharma Guy - July 21, 2014

OH MY GOD! DRUG SIDE EFFECTS KILLED KENNY!

Pharma Guy - August 13, 2013

Revolution Health and the Wisdom of Crowds

Pharma Guy - January 24, 2007

1...99100101...240 Page 100 of 240

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

Researcher analyzing genetic data for an ultra-rare disease alongside physicians, DNA imagery, and patient silhouettes representing rare disease awareness and patient identification.

How Do You Market a Disease That Doesn’t Officially Exist?

August 6, 2026

Healthcare professional reviewing a plain-language clinical trial summary with a patient, illustrating how transparent communication strengthens trust, patient engagement, and pharmaceutical marketing.

The Plain-Language Revolution: How Compliance Is Becoming a Marketing Advantage

August 5, 2026

Healthcare professional reviewing a personalized medication dosing plan, illustrating flexible dosing strategies that support patient persistence and individualized treatment.

Could Flexible Dosing Become Pharma’s Next Competitive Advantage?

August 4, 2026